Straightforward Synthesis of Functionalized 4,5,6,7‐Tetrahydro‐pyrazolo[1,5‐a]pyrazines – Important Building Blocks for Medicinal Chemistry

[1]  D. Volochnyuk,et al.  Selective α-Methylation of Ketones. , 2021, The Journal of organic chemistry.

[2]  D. Volochnyuk,et al.  Cu-Catalyzed Pyridine Synthesis via Oxidative Annulation of Cyclic Ketones with Propargylamine. , 2021, Journal of Organic Chemistry.

[3]  Dragos Horvath,et al.  Chemography: Searching for Hidden Treasures , 2020, J. Chem. Inf. Model..

[4]  L. Kattner,et al.  Sulfoximines as Rising Stars in Modern Drug Discovery? Current Status and Perspective on an Emerging Functional Group in Medicinal Chemistry. , 2020, Journal of medicinal chemistry.

[5]  Shuai Liang,et al.  Recent Advances in the Synthesis and Direct Application of Sulfinate Salts , 2020 .

[6]  D. Volochnyuk,et al.  Electrochemical Scaled‐up Synthesis of Cyclic Enecarbamates as Starting Materials for Medicinal Chemistry Relevant Building Bocks , 2020 .

[7]  D. Volochnyuk,et al.  Semi-Industrial Fluorination of β-Keto Esters with SF4: Safety vs Efficacy , 2020, Synlett.

[8]  O. Grygorenko,et al.  The symbiotic relationship between drug discovery and organic chemistry. , 2020, Chemistry.

[9]  N. M. Tsizorik,et al.  Synthesis of 4-aryl(hetaryl)pyrazolo[1,5-a]pyrazines by palladium-catalyzed Suzuki–Miyaura cross coupling , 2019, Chemistry of Heterocyclic Compounds.

[10]  O. Grygorenko,et al.  Scalable Synthesis of Biologically Relevant Spirocyclic Pyrrolidines , 2019, ACS omega.

[11]  Alexandre Varnek,et al.  Evolution of commercially available compounds for HTS. , 2019, Drug discovery today.

[12]  R. Zaki,et al.  A Concise Review on the Synthesis and Reactions of Pyrazolopyrazine Heterocycles , 2018, Journal of Heterocyclic Chemistry.

[13]  M. Vovk,et al.  Synthesis of 8Н-pyrazolo[5',1':3,4]pyrazino[2,1-b]quinazolin-8-ones , 2017, Chemistry of Heterocyclic Compounds.

[14]  P. Lindsay-Scott,et al.  A Flexible Strategy for the Regiocontrolled Synthesis of Pyrazolo[1,5-a]pyrazines. , 2017, Journal of Organic Chemistry.

[15]  Warren R. J. D. Galloway,et al.  Partially Saturated Bicyclic Heteroaromatics as an sp3‐Enriched Fragment Collection , 2016, Angewandte Chemie.

[16]  Takayoshi Yamamoto,et al.  Synthesis, structure-activity relationships and biological evaluation of 4,5,6,7-tetrahydropyrazolopyrazines as metabotropic glutamate receptor 5 negative allosteric modulators. , 2016, Bioorganic & medicinal chemistry letters.

[17]  Jonas Boström,et al.  Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone? , 2016, Journal of medicinal chemistry.

[18]  Yipin Lu,et al.  Structure-Based Drug Design of Novel Potent and Selective Tetrahydropyrazolo[1,5-a]pyrazines as ATR Inhibitors. , 2015, ACS medicinal chemistry letters.

[19]  Matthew W D Perry,et al.  Designing novel building blocks is an overlooked strategy to improve compound quality. , 2015, Drug discovery today.

[20]  C. Blackburn,et al.  Histone deacetylase inhibitors derived from 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine and related heterocycles selective for the HDAC6 isoform. , 2014, Bioorganic & medicinal chemistry letters.

[21]  S. S. Kovalenko,et al.  Facile one-pot synthesis of the pyrazolo[1,5-a]pyrazine scaffold , 2013, Chemistry of Heterocyclic Compounds.

[22]  Ping Wang,et al.  A Concise Synthesis of a Tetrahydropyrazolopyrazine Building Block , 2012 .

[23]  C. Marson,et al.  New and unusual scaffolds in medicinal chemistry. , 2011, Chemical Society reviews.

[24]  S. F. Macdonald,et al.  Faktoren für die Auswahl organischer Reaktionen in der medizinischen Chemie und die Anwendung dieser Reaktionen in Arrays (kleinen fokussierten Bibliotheken) , 2010 .

[25]  Simon J F Macdonald,et al.  Factors determining the selection of organic reactions by medicinal chemists and the use of these reactions in arrays (small focused libraries). , 2010, Angewandte Chemie.

[26]  Matthew E Welsch,et al.  Privileged scaffolds for library design and drug discovery. , 2010, Current opinion in chemical biology.

[27]  H. M. Langford,et al.  Design and synthesis of substituted 4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxamides, novel HIV-1 integrase inhibitors. , 2008, Bioorganic & medicinal chemistry letters.

[28]  D. Connolly,et al.  Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109a. , 2007, Bioorganic & medicinal chemistry letters.